Table 3.
Healthcare disruption and telehealth utilization during COVID-19 pandemic
|
MS |
HC |
MS vs. HC | |||
|---|---|---|---|---|---|
| MS Care (n=69 Received Care) | n | No. (%) | n | No. (%) | PValue |
| Missed/Canceled appointment | 68 | 26 (38.2) | – | – | – |
| Experienced a delay | 66 | 26 (39.4) | – | – | – |
| Attended in-person appointment | 69 | 27 (39.1) | – | – | – |
| Attended telehealth appointment | 69 | 42 (60.9) | – | – | – |
| In-person vs telehealth | .014 | – | |||
| P Value | P Value | ||||
| Non-MS Medical Care (n = 157) | n | No. (%) | n | No. (%) | P Value |
| Missed/Canceled appointment | 62 | 23 (37.1) | 88 | 58 (65.9) | <.001 |
| Experienced a delay | 62 | 31 (50.0) | 83 | 55 (66.3) | .049 |
| Attended in-person appointment | 61 | 24 (39.3) | 87 | 37 (42.5) | NS |
| Attended telehealth appointment | 62 | 37 (59.7) | 87 | 33 (37.9) | .009 |
| In-person vs. Telehealth | 0.012 | NS | |||
| P Value | P Value | ||||
| Mental Healthcare (n=51) | n | No. (%) | n | No. (%) | P Value |
| Missed/canceled appointment | 30 | 10 (33.3) | 19 | 5 (26.3) | NS |
| Experienced a delay | 30 | 6 (20.0) | 19 | 5 (26.3) | NS |
| Attended in-person appointment | 29 | 5 (17.2) | 19 | 3 (15.8) | NS |
| Attended telehealth appointment | 30 | 27 (90.0) | 19 | 15 (79.0) | NS |
| In-person vs telehealth | <.001 | .001 | |||
| P Value | P Value | ||||
| Miscellaneous | |||||
| Chose not to seek emergency care | 59 | 7 (11.9) | 65 | 11 (16.9) | NS |
| Difficulty fulfilling prescriptions | 65 | 8 (12.3) | 77 | 12 (15.6) | NS |
NOTE. Between-subject differences were analyzed by Pearson's chi-square tests (MS vs HC). Within-subject differences were examined using McNemar's test (in-person vs telehealth).
Abbreviation: NS, not statistically significant.